IL4 and asthma: Unfortunately, the use of a neutralizing antibody against IL-4 did not prove very effective in asthma therapy [9], and although the use of an IL-4 (and IL-13) receptor inhibitor during the effector phase showed promising results [10], the low number of study participants (24 – 32) reduces the validity of these results.